01 December 2005
IgG subclass antibody response to mycobacterial serine protease at differentstages of pulmonary tuberculosis.
Sonika Gupta, Niraj Shende, Amarjeet Bhatia, Satish Kumar, Bhaskar HarinathMed Sci Monit 2005; 11(12): CR585-588 :: ID: 438856
Abstract
Background: Tuberculosis (TB) is a chronic bacterial infection caused by M. Tuberculosis. Studies of antibody response in TB have focussed mainly on their usefulness as a diagnosticserological tool, with little attention given to analysis of antibodies at the isotype and subclass levelin relation to disease pathogenesis. Hence the present study was done to analyse IgG subclass responseat different stages of tuberculosis, in order to understand the immunological events associated withdisease development. Material/Methods: Sera samples were collected from 104 subjects: 79 tuberculosispatients (fresh, relapse and chronic cases) and 25 healthy normals. IgG subclass antibody response wasanalysed by indirect plate peroxidase ELISA against previously reported mycobacterial serine protease(ES-31) antigen. Results: Fresh cases of tuberculosis showed increased IgG1 and IgG3 antibodies, whilea few cases showed moderately increased IgG2. IgG1 and IgG3 were found to be elevated with increasedbacillary load. Relapse and chronic cases showed increased IgG1 and IgG3, while positivity to IgG2 wasdecreased. Chronic cases showed a moderate increase in IgG4 antibody. Thus IgG1 and IgG3 were predominantin all forms of tuberculosis. Conclusions: The elevated levels of IgG1 and IgG3 antibodies to mycobacterialserine protease in active tuberculosis observed in this study provide an additional marker for diagnosisof tuberculosis. Furthermore, the higher level of these antibodies with high bacillary load patientsand in chronic cases of tuberculosis may provide valuable insight into their possible role in diseaseprogression.
Keywords: Antibodies, Bacterial - blood, Antibody Formation, Biological Markers, Immunoglobulin G - blood, Mycobacterium tuberculosis - immunology, Serine Endopeptidases - immunology, Tuberculosis, Pulmonary - diagnosis
Editorial
01 March 2025 : Editorial
Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical TrialsDOI: 10.12659/MSM.948672
Med Sci Monit 2025; 31:e948672
In Press
Clinical Research
Exploring the Association Between Serum Neurogranin, Nardilysin, and Ischemic Stroke: A Case-Control Study ...Med Sci Monit In Press; DOI: 10.12659/MSM.947703
Clinical Research
Comparative Analysis of Laser Therapies for Striae Distensae: Fractional CO₂ vs Combined Q-Switch Nd:YAGMed Sci Monit In Press; DOI: 10.12659/MSM.947464
Database Analysis
Utility of Central Venous Oxygen Saturation Gradient in Predicting Mortality in Dialysis with Catheter AccessMed Sci Monit In Press; DOI: 10.12659/MSM.947298
Clinical Research
Intraoperative Renal Near-Infrared Spectroscopy Monitoring as a Predictor of Renal Outcomes in Cardiac SurgeryMed Sci Monit In Press; DOI: 10.12659/MSM.947462
Most Viewed Current Articles
17 Jan 2024 : Review article 7,094,149
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,321
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 27,595
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 21,787
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912